Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors

Cancer Research

Volumn 61, Issue 12, 2001, Pages 4885-4891

  Kusama, T ^a   Mukai, M ^a   Iwasaki, T ^a   Tatsuta, M ^a   Matsumoto, Y ^a   Akedo, H ^a   Nakamura, H ^a  

^a Osaka Medical Center and Cancer and Cardiovascular Diseases   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; EPIDERMAL GROWTH FACTOR; FARNESOL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; RHO FACTOR; TRANSFERASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CLOSTRIDIUM BOTULINUM; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; ONCOGENE C ERB; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ACTINS; ADP RIBOSE TRANSFERASES; BOTULINUM TOXINS; CELL MEMBRANE; CYTOSKELETON; CYTOSOL; EPIDERMAL GROWTH FACTOR; FATTY ACIDS, MONOUNSATURATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RHOA GTP-BINDING PROTEIN; TUMOR CELLS, CULTURED;

EID: 0035874879     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Carcinoma of the pancreas: A critical analysis of costs, results of resections, and the need for standardized reporting
2. Cancer statistics
3. Role of growth factors in pancreatic cancer
4. A negative feedback loop attenuates EGF-induced morphological changes
5. Epidermal growth factor induces rapid organization of the actin microfilament system in human A431 cells
6. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products
7. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors
8. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia
9. Rho GTPases and the actin cytoskeleton
10. Cdc42 and rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K
11. Integrin-mediated signals regulated by members of the Rho family of GTPases
12. Rho-mediated protein tyrosine phosphorylation in lysophosphatidic acid induced tumor cell invasion
13. Small GTP-binding protein Rho stimulates the actomyosin system, leading to invasion of tumor cells
14. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells
15. 4 integrin and cAMP metabolism
16. Branch-point reactions in the biosynthesis of cholesterol, dolichol, ubiquinone and prenylated proteins
17. Regulation of the mevalonate pathway
18. The GTPase superfamily: A conserved switch for diverse cell functions
19. Inhibition of pancreatic adenocarcinoma cell growth by lovastatin
20. Reduction of mouse mammary tumor formation and metastasis by lovastatin, an inhibitor of the mevalonate pathway of cholesterol synthesis
21. Inhibitory effect of lovastatin on spontaneous metastasis derived from a rat lymphoma
22. Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis
23. Low density lipoproteins and lovastatin modulate the organ-specific transendothelial migration of primary and metastatic human colon adenocarcinoma cell lines in vitro
24. A rapid in vitro assay for quantitating the invasive potential of tumor cells
25. Regulation of intracellular actin polymerization by prenylated cellular proteins
26. Role of rho protein in lovastatin-induced breakdown of actin cytoskeleton
27. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line
28. Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis
29. Low density lipoprotein receptor activity in human intracranial tumors and its relation to the cholesterol requirement
30. Increase in the active form of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatocellular carcinoma: Possible mechanism for alteration of cholesterol biosynthesis
31. Prognostic value of low density lipoprotein receptor expression in colorectal carcinoma
32. Enhanced 3-hydroxy-3-methylglutaryl coenzyme A reductase in human colorectal cancer not expressing low density lipoprotein receptor
33. Cell cycle-specific effects of lovastatin
34. 1 to multiple cell cycle by lovastatin
35. Stimulation of human breast cancer MCF-7 cells with estrogen prevents cell cycle arrest by HMG-CoA reductase inhibitors
36. Effect of pravastatin, a potent 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on survival of AH130 hepatoma-bearing rats
37. Fluvastatin: A review of its pharmacology and use in the management of hypercholesterolaemia
38. Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor
39. Insulin and glucagon modulate hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity by affecting immunoreactive protein levels
40. Stimulatory effect of PDGF on HMG-CoA reductase activity and N-linked glycosylation contributes to increased expression of IGF-1 receptors in human fibroblasts
41. Tyrosine kinase-dependent modulation of 3-hydroxy-3-methylglutaryl-CoA reductase in human breast adenocarcinoma SKBR-3 cells
42. Epidermal growth factor stimulates 3-hydroxy-3-methylglutaryl-coenzyme A reductase expression via the ErbB-2 pathway in human breast adenocarcinoma cells
43. Signal transduction by receptors with tyrosine kinase activity
44. Protein modules and signaling networks
45. Regulation of chemotaxis by the platelet-derived growth factor receptor-β
46. Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling
47. A role for epidermal growth factor receptor, c-Src and focal adhesion kinase in an in vitro model for the progression of colon cancer
48. Epidermal growth factor receptor-mediated cell motility: Phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement
49. HMG-CoA reductase inhibitor-induced L6 myoblast cell death: Involvement of the phosphatidylinositol 3-kinase pathway
50. Phase 1 study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer